Emerging Regional Markets for Therapeutic Drugs

July 07, 2011

Wellesley, Mass. – In a recent release, EMERGING REGIONAL MARKETS FOR THERAPEUTIC DRUGS (PHM076A) from BCC Research (www.bccresearch.com), the emerging market value of therapeutic drugs was nearly $146 billion in 2010. That value is projected to be $214 billion in 2015, after increasing at a five-year compound annual growth rate (CAGR) of 8%.

The emerging market for therapeutic drugs can be broken down into eight segments by region – Latin America, Eastern Europe, China, Middle East, South Korea, India, Russia, and South Africa.

The region made up of Latin America was valued at $38 billion in 2010, and in 2015 should be worth $55.3 billion, yielding a CAGR of 7.8%.

The region made up of Eastern Europe, worth $32.2 billion in 2010, should rise to $55.5 billion in 2015 at a CAGR of 11.5%.

The region made up of China was worth $33.3 billion in 2010, and should reach a value of nearly $44.7 billion in 2015, a CAGR of 6.2%.

The region made up of the Middle East was valued at $16.6 billion in 2010 and in 2015 should be worth nearly $24.4 billion, growing at a CAGR of 8%.

The region made up of South Korea was worth nearly $8.1 billion in 2010 and in 2015 should decrease to $7.3 billion, a CAGR of -1.9%.

The region made up of India was worth nearly $8.3 billion in 2010, and should reach a value of nearly $14.4 billion in 2015, a CAGR of 11.7%.

The region made up of Russia was valued at $7.4 billion in 2010, and in 2015 should be worth nearly $10.5 billion, growing at a CAGR of 7.1%.

The region made up of South Africa was worth $2.18 billion in 2010 and in 2015 should decrease to  $2.17 billion in 2015, a CAGR of -0.1%

These emerging markets are extremely dissimilar and diverse and therefore cannot be approached uniformly. Based on certain key factors, they vary according to their patented pharmaceuticals, biologics, generics, biosimilars, vaccines, and other relevant therapeutic classes.

One of the most important market drivers fueling growth is the increased aging of patients in emerging markets as well as the ability of these patients to pay for, or have paid for, leading healthcare. This dynamic alone is expected to continue contributing substantially to market growth in the future.

This report will be an invaluable tool for business planners, acquisitions specialists, licensing strategists, product managers, market research analysts, investors, and anyone interested in emerging geographic markets, its products, industry participants, and its future.

To Contact us, click here  

Emerging Regional Markets for Therapeutic Drugs( PHM076A )
Publish Date: Feb 2011    

Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.